UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bullous pemphigoid

Anais brasileiros de dermatología, 2019-03, Vol.94 (2), p.133-146

2019

Volltextzugriff (PDF)

Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid

Journal of investigative dermatology, 2016-11, Vol.136 (11), p.2201-2210

2016

Volltextzugriff (PDF)

Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase‐4 inhibitor‐related bullous pemphigoid

Journal of dermatology, 2018-05, Vol.45 (5), p.596-599

2018

Volltextzugriff (PDF)

Bullous pemphigoid exacerbated by nivolumab and temporally rescued with therapeutic plasma exchange

Journal of dermatology, 2024-05, Vol.51 (5), p.e149-e150

2024

Volltextzugriff (PDF)

A case of anti‐laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase‐4 inhibitor administration

Journal of dermatology, 2024-06, Vol.51 (6), p.869-872

2024

Volltextzugriff (PDF)

Case report: Bullous pemphigoid combined with Sjögren's syndrome complicated by central nervous system infection

Frontiers in immunology, 2024-09, Vol.15, p.1419054

2024

Volltextzugriff (PDF)

Unique Scabies Presentation in a Patient with Bullous Pemphigoid

The American journal of tropical medicine and hygiene, 2024-09, Vol.111 (3), p.455-456

2024

Volltextzugriff (PDF)

Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid

Acta dermato-venereologica, 2023-03, Vol.103, p.adv00888-adv00888

2023

Volltextzugriff (PDF)

Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome

Scientific reports, 2015-12, Vol.5 (1), p.18001-18001, Article 18001

2015

Volltextzugriff (PDF)

Targeting antibody-mediated complement-independent mechanism in bullous pemphigoid with diacerein

Journal of dermatological science, 2024-04, Vol.114 (1), p.44-51

2024

Volltextzugriff (PDF)

Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin β4 subunit

British journal of dermatology (1951), 2024-06, Vol.191 (1), p.140-141

2024

Volltextzugriff (PDF)

A case of bullous pemphigoid complicated by mucosal lesions due to mucosal‐dominant pemphigus vulgaris: analyzing the pathogenicity of anti‐desmoglein 3 antibodies using a bead aggregation assay

International journal of dermatology, 2024-07, Vol.63 (7), p.956-958

2024

Volltextzugriff (PDF)

Analysis of the Clinical Characteristics of Dipeptidyl Peptidase-4 Inhibitor-Induced Bullous Pemphigoid

The Annals of pharmacotherapy, 2022-02, Vol.56 (2), p.205-212

2022

Volltextzugriff (PDF)

Detection of anti‐BP180 NC16A autoantibodies after the onset of dipeptidyl peptidase‐IV inhibitor‐associated bullous pemphigoid: a report of three patients

British journal of dermatology (1951), 2018-09, Vol.179 (3), p.790-791

2018

Volltextzugriff (PDF)

Omalizumab therapy for bullous pemphigoid

Journal of the American Academy of Dermatology, 2014-09, Vol.71 (3), p.468-474

2014

Volltextzugriff (PDF)

Checkpoint inhibitor‐associated bullous cutaneous immune‐related adverse events: a multicentre observational study

British journal of dermatology (1951), 2022-12, Vol.187 (6), p.981-987

2022

Volltextzugriff (PDF)

A Case of Nivolumab‐Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein‐1/Programmed Death Ligand‐1 Inhibitors and Recommendations for Diagnosis and Management

The oncologist (Dayton, Ohio), 2018-10, Vol.23 (10), p.1119-1126

2018

Volltextzugriff (PDF)

Relationship between bullous pemphigoid and malignancy: A Mendelian randomization study

Journal of dermatology, 2024-03, Vol.51 (3), p.403-408

2024

Volltextzugriff (PDF)

Diagnosis and treatment of bullous pemphigoid that developed twice after total knee replacement arthroplasty: a case report

BMC musculoskeletal disorders, 2021-01, Vol.22 (1), p.118-118, Article 118

2021

Volltextzugriff (PDF)

Gliptin-induced bullous pemphigoid

International journal of clinical pharmacology and therapeutics, 2024-02, Vol.62 (2), p.89-95

2024

Volltextzugriff (PDF)

Missed drug-induced bullous pemphigoid leads to longer immunosuppression than recognized cases: A 9-year retrospective review

Journal of the American Academy of Dermatology, 2020-05, Vol.82 (5), p.1255-1258

2020

Volltextzugriff (PDF)

Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1

Cancer immunology research, 2016-05, Vol.4 (5), p.383-389

2016

Volltextzugriff (PDF)

Nodular formation in anti‐laminin γ1 pemphigoid

Journal of dermatology, 2020-03, Vol.47 (3), p.e80-e82

2020

Volltextzugriff (PDF)

Bullous pemphigoid induced by dipeptidyl peptidase‐4 inhibitors. Eight cases with clinical and immunological characterization

International journal of dermatology, 2018-07, Vol.57 (7), p.810-816

2018

Volltextzugriff (PDF)

A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab

Melanoma research, 2015-06, Vol.25 (3), p.265-268

2015

Volltextzugriff (PDF)

1 – 25 von 875

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical And Experimental Dermatology

Nur zeigenMit Volltextzugriff

ThemaMiddle Aged

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(725)

Publikationsform

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(869)
Science & Technology
(650)
Life Sciences & Biomedicine
(646)
Dermatology
(514)
Male
(509)
Female
(490)
Pemphigoid, Bullous - Pathology
(278)
Pemphigoid, Bullous - Drug Therapy
(272)
Pemphigoid, Bullous - Diagnosis
(252)
Pemphigoid, Bullous - Immunology
(237)
Bullous Pemphigoid
(226)
Biological And Medical Sciences
(218)
Medical Sciences
(217)
Aged, 80 And Over
(198)
Pemphigoid, Bullous - Complications
(181)
Bullous Diseases Of The Skin
(149)
Diagnosis, Differential
(119)
Pemphigoid, Bullous - Chemically Induced
(108)
Skin - Pathology
(102)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Bullous pemphigoid

Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid

Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase‐4 inhibitor‐related bullous pemphigoid

Bullous pemphigoid exacerbated by nivolumab and temporally rescued with therapeutic plasma exchange

A case of anti‐laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase‐4 inhibitor administration

Case report: Bullous pemphigoid combined with Sjögren's syndrome complicated by central nervous system infection

Unique Scabies Presentation in a Patient with Bullous Pemphigoid

Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid

Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome

Targeting antibody-mediated complement-independent mechanism in bullous pemphigoid with diacerein

Sensitive and specific assay for the serological diagnosis of anti-p200 pemphigoid based on the recombinant laminin β4 subunit

A case of bullous pemphigoid complicated by mucosal lesions due to mucosal‐dominant pemphigus vulgaris: analyzing the pathogenicity of anti‐desmoglein 3 antibodies using a bead aggregation assay

Analysis of the Clinical Characteristics of Dipeptidyl Peptidase-4 Inhibitor-Induced Bullous Pemphigoid

Detection of anti‐BP180 NC16A autoantibodies after the onset of dipeptidyl peptidase‐IV inhibitor‐associated bullous pemphigoid: a report of three patients

Omalizumab therapy for bullous pemphigoid

Checkpoint inhibitor‐associated bullous cutaneous immune‐related adverse events: a multicentre observational study

A Case of Nivolumab‐Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein‐1/Programmed Death Ligand‐1 Inhibitors and Recommendations for Diagnosis and Management

Relationship between bullous pemphigoid and malignancy: A Mendelian randomization study

Diagnosis and treatment of bullous pemphigoid that developed twice after total knee replacement arthroplasty: a case report

Gliptin-induced bullous pemphigoid

Missed drug-induced bullous pemphigoid leads to longer immunosuppression than recognized cases: A 9-year retrospective review

Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1

Nodular formation in anti‐laminin γ1 pemphigoid

Bullous pemphigoid induced by dipeptidyl peptidase‐4 inhibitors. Eight cases with clinical and immunological characterization

A case of bullous pemphigoid in a patient with metastatic melanoma treated with pembrolizumab

Aktive Filter

Suchergebnisse filtern